a public good project by the
Synthesis
Company
of California

© 2026

Helga Schmetzer | doi.page

0 works0 citations0 h-index

Helga Schmetzer

Comprehensive Cancer Center Mainfranken(DE)München Klinik(DE)Comprehensive Cancer Center Erlangen(DE)

Publications by Year

Research Areas

Immunotherapy and Immune Responses, Acute Myeloid Leukemia Research, CAR-T cell therapy research, Immune Cell Function and Interaction, T-cell and B-cell Immunology

Most-Cited Works

→ Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia(2017)167 cited
→ Glucocorticoid-Induced Tumor Necrosis Factor Receptor–Related Protein Ligand Subverts Immunosurveillance of Acute Myeloid Leukemia in Humans(2009)74 cited
→ Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies(2004)72 cited
→ High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML)(2004)72 cited
Membrane-bound heat shock protein 70 (Hsp70) in acute myeloid leukemia: a tumor specific recognition structure for the cytolytic activity of autologous NK cells.(2003)
→ Dendritic Cells (DCs) Can Be Successfully Generated From Leukemic Blasts in Individual Patients With AML or MDS(2010)66 cited

→ Soluble CD137 (4-1BB) Ligand Is Released Following Leukocyte Activation and Is Found in Sera of Patients with Hematological Malignancies(2001)

66 cited

→ Antigen-Presenting Cells: Potential of Proven und New Players in Immune Therapies(2020)50 cited

→ High HSP70-membrane expression on leukemic cells from patients with acute myeloid leukemia is associated with a worse prognosis(2006)45 cited

→ Adoptive transfer of human natural killer cells in mice with severe combined immunodeficiency inhibits growth of Hsp70-expressing tumors(2000)45 cited